4553 — Towa Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual balance sheet for Towa Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2019 March 31st	C2020 March 31st	2021 March 31st	C2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	31,761	18,713	22,915	32,830	24,257
Net Total Accounts Receivable
Net Total Receivables	34,576	41,572	45,784	50,748	54,392
Total Inventory
Total Other Current Assets
Total Current Assets	108,206	121,525	137,290	166,864	182,990
Net Property, Plant And Equipment	73,663	81,629	85,898	99,873	127,004
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	188,803	230,016	245,668	332,097	371,347
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	37,177	70,164	51,516	115,073	78,529
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	97,032	125,351	129,069	199,928	234,453
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	91,771	104,665	116,599	132,169	136,894
Total Liabilities & Shareholders' Equity	188,803	230,016	245,668	332,097	371,347
Total Common Shares Outstanding